市場調查報告書
商品編碼
1198855
Zygoma 和 Pteryx 植入物市場——增長、趨勢和預測 (2023-2028)Zygomatic and Pterygoid Implants Market - Growth, Trends, and Forecasts (2023 - 2028) |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計在預測期內,顴骨和翼狀骨植入物市場的複合年增長率為 5.9%。
COVID-19 的爆發已成為牙科面臨的重大挑戰。 對感染病毒的恐懼以及牙科手術程序和在線諮詢的推遲是導致牙科診所訪問量下降的主要因素。 例如,2020 年 3 月,美國牙科協會 (ADA) 決定將選擇性牙科護理推遲到牙科診所,並用患者代替僅限急診的牙科護理,以避免給醫院急診科帶來負擔。建議提供服務。 這導致對顴骨和翼骨植入物的需求下降,對整個市場產生了重大影響。 但是,隨著 COVID-19 病例數量下降和服務恢復,預計在未來兩到三年內將從這種影響中恢復過來。
口腔疾病患病率上升、口腔健康意識增強以及對美容牙科的需求增加是預計將推動顴骨和翼狀骨植入物市場增長的關鍵因素。 例如,根據世衛組織 2022 年 11 月的估計,口腔疾病影響全球近 35 億人,其中四分之三的受影響人口生活在中等收入國家。 此外,據美國牙科協會稱,到 2022 年 11 月,全球口腔疾病病例數將在過去 30 年中增加 10 億。 隨著牙科疾病的增加,預計對顴骨和翼骨植入物的需求將增加,從而推動市場增長。 此外,根據美國美學牙科學會的一項研究,到 2022 年 11 月,普通患者將在美容牙科手術上花費超過 10,000 美元。 預計如此高的美容牙科支出將增加對顴骨和翼狀□肉植入手術的需求。 因此,在預測期內推動市場增長。
此外,正在舉辦許多關於顴骨和翼狀□肉植入物的課程和研討會以推進治療,預計這將提高對這些植入物的認識,從而刺激市場的增長。。 例如,2022 年 6 月舉行的 2022 年口腔重建基金會 (ORF) 國際研討會將重點教育和培訓更多牙醫進行顴骨和翼狀□肉種植體的 all-on-X 牙種植體手術。 此類課程和培訓有望提高手術的效率和安全性,從而提高牙醫對顴骨和翼狀骨植入物治療的認識,從而推動市場的增長。 因此,上述因素共同歸因於預測期內研究的市場增長。 然而,與種植體相關感染相關的並發症發生率不斷增加是製約市場增長的主要因素。
上頜骨嚴重萎縮部分預計將佔據很大的市場份額。 當下頜骨開始惡化時,就會發生骨萎縮,也稱為下頜骨壞死。 該細分市場的增長因素是上頜骨嚴重萎縮的發生率增加、老年人口增加以及市場參與者實施戰略舉措。 例如,根據《聯合國2022年世界人口老齡化亮點》,2021年全球65歲及以上人口將達到7.71億,預計2030年老年人口將達到9.94億。 老齡化社會易患上頜骨吸收、骨量增加等牙科疾病。
此外,根據國家醫學圖書館 2021 年 1 月發表的一篇文章,顴骨植入物是一種低成本、低並發症、低發病率、治療時間短且相對便宜的正式植骨技術替代方法. 這些研究預計將提供高存活率,反映了對顴骨種植體的需求不斷增加以治療上頜骨嚴重萎縮,從而促進了該細分市場的增長。 此外,根據 Acta Odontologica Scandinavica 於 2021 年 12 月發表的一篇論文,與接受顴骨種植體支持的全口修復體相比,接受顴骨種植體支持的全口義齒修復的患者口腔健康相關生活質量顯著改善,口腔健康相關生活質量顯著改善。嚴重的上頜骨萎縮。對治療表示總體滿意。 此類研究證明了翼狀□肉植入物的好處,並且由於其越來越多的採用,在預測期內推動了市場的增長。 因此,由於上述因素,預計該部分在預測期內將顯著增長。
由於人口老齡化導致牙科疾病和傷害的發生率上升,以及顴骨種植手術對上頜骨吸收修復的好處,歐洲在全球顴骨和翼狀□肉種植體市場佔據主導地位。預計將佔據很大的市場份額。 例如,根據聯合國人口基金發布的2022年統計數據,德國、英國、法國和意大利估計有22%、19%、21%和24%的65歲及以上人口處於分別為 2022 年。 同樣,根據歐洲牙周病學會的數據,牙周病是歐洲最常見的疾病。 35歲以上的人中,十個有八個患有牙周病。 此外,牙周病是成人和老年人口支出的主要原因。 因此,預計老年人口中牙科疾病的增加將推動市場的發展。
根據研究,顴骨和翼骨植入物的有效治療似乎也推動了市場增長。 例如,國家醫學圖書館 2021 年 6 月發表的一篇論文指出,顴骨和翼狀□肉植入物已被提議作為歐洲重度吸收上頜骨康復的解決方案。 它還表明,進一步研究整個手術過程的準確性對於避免嚴重的手術並發症和外周解剖事故至關重要。 這種手術的優勢有望推動市場增長。 這樣,通過上述新興市場的發展,該市場有望在歐洲實現顯著增長。
The zygomatic and pterygoid implants market is expected to register a CAGR of 5.9% over the forecast period.
The onset of COVID-19 presented a significant challenge for dentistry. The fear of getting infected with the virus and the postponement of dental surgery procedures and online consultation were the major factors that contributed to decreased visits to dental clinics. For instance, in March 2020, the American Dental Association (ADA) recommended that dental practices postpone elective dental procedures and provide emergency-only dental services to help keep patients from burdening hospital emergency departments. This subsequently leads to a decrease in demand for zygomatic and pterygoid implants, which has majorly affected the overall market. However, with the decline in COVID-19 cases and resumption of services, the studied market is expected to recover from the effect in the next two-three years.
The increasing prevalence of oral diseases, rising awareness about oral health, and growing demand for cosmetic dentistry are the major factors that are expected to drive the growth of the zygomatic and pterygoid implant market. For instance, as per November 2022 estimates of the WHO, oral diseases affected close to 3.5 billion people worldwide, with 3 out of 4 people affected living in middle-income countries. Furthermore, according to American Dental Association, in November 2022, the global cases of oral diseases have increased by 1 billion over the last 30 years. With such an increase in dental disease, the demand for zygomatic and pterygoid implants is expected to increase, driving growth in the market. Additionally, according to a survey by the American Academy of Cosmetic Dentistry, in November 2022, an average patient spent more than USD 10,000 on dental cosmetic procedure visits. Such high cosmetic dentistry spending is expected to increase the demand for zygomatic and pterygoid implant procedures. Thus, driving the market growth over the forecast period.
Furthermore, many courses and symposiums on zygomatic and pterygoid implants are being held for treatment advancements that are expected to increase the awareness about these impants and hence, adding to the growth of the market. For instance, in June 2022, the Oral Reconstruction Foundation (ORF) International Symposium 2022, made a concerted effort to educate and train more dentists on All-on-X dental implant procedures for zygomatic and pterygoid implants. Such courses and training are expected to increase the efficiency and higher safety of that procedure thus increasing awareness of zygomatic and pterygoid implant treatments among dentists and driving the growth of the market. Therefore, the factors mentioned above are attributed collectively to the studied market growth over the forecast period. However, the growing rate of complications linked to implant-associated infections is a major factor restraining the market's growth.
The severe atrophy of the maxillary bone segment is expected to hold a significant market share. Bone atrophy also referred to as osteonecrosis of the jaw occurs when the underlying jawbone begins to deteriorate. The factors contributing to the segment's growth are the increasing incidences of severe atrophy of the maxillary bone, the growing geriatric population, and the implementation of strategic initiatives by the market players. For instance, according to World Population Aging Highlight United Nations 2022, in 2022, there were 771 million people aged 65 years or over globally in 2021, and the older population is projected to reach 994 million by 2030. As the aging population is prone to suffering from dental ailments such as maxillary resorption and increased bone loss, the demand for zygomatic and pterygoid implants is expected to grow with the growing geriatric population.
Furthermore, as per a January 2021 published article by the National Library of Medicine, zygomatic implants appear to offer a promising alternative to formal bone grafting techniques with lower costs, fewer complications, less morbidity, shorter treatment times, and comparably high survival rates, such studies reflect the growing demand for zygomatic implants for severe atrophy of the maxilla, thereby contributing to the segment's growth. Additionally, according to an article published by Acta Odontologica Scandinavica, in December 2021, patients rehabilitated with zygomatic implant-supported complete dental prostheses showed substantial improvements in Oral health-related quality of life and general satisfaction with the treatment received by patients with severe maxillary bone atrophy. Such studies indicate the advantages of pterygoid implants which lead to growing adoption thus driving the growth of the market over the forecast period. Hence, due to the above-mentioned factors, the segment is expected to grow significantly over the forecast period.
Europe is expected to hold a significant market share in the global zygomatic and pterygoid implants market due to the increase in the geriatric population leading to a rise in incidence rates of dental ailments & injuries and the advantage of zygomatic implant procedures for rehabilitation of resorbed maxillary bone. For instance, according to the 2022 statistics published by the United Nations Population Fund, Germany, the United Kingdom, France, and Italy estimated 22%, 19%, 21%, and 24% of the population respectively is aged 65 years and above in 2022. Likewise, according to the European Federation of Periodontology, in Europe, periodontal diseases are the most common conditions. Eight out of ten individuals aged over 35 years of age suffer from gum diseases. In addition, periodontal diseases represent a major cause of expenditure in the adult and geriatric population. Therefore, an increase in dental disease in the geriatric population is expected to drive the market.
The research studies suggest that effective treatment with zygomatic and pterygoid implants is also propelling the growth of the market. For instance, an article published by the National Library of Medicine, in June 2021, stated that zygomatic and pterygoid implants have been suggested as a solution to rehabilitate severely resorbed maxillary bone in Europe. It also suggested that further research on the accuracy of the entire procedure is mandatory to avoid critical surgical complications, which can involve accidents to the surrounding anatomy. Such an advantage of the procedure is expected to drive the growth of the market. Thus, due to the above-mentioned developments, the market is expected to witness significant growth in Europe.
The zygomatic and pterygoid implants market is consolidated in nature due to the presence of a few major companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international and local companies that hold significant market shares and are well-known, including Straumann Holding AG, Noris Medical, S.I.N. Implant System, Southern Implants, and IDC Implant & Dental Company, among others.